Study of DF6215 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)
- Status
- COMPLETED
- Phase
- PHASE1
Immunology of Ebola Vaccine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- Status
- RECRUITING
- Phase
- PHASE3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters
- Status
- COMPLETED
- Phase
- NA
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
- Status
- RECRUITING
- Phase
- PHASE2
CAE for Poorly Adherent Individuals With Schizophrenia
- Status
- COMPLETED
- Phase
- NA
A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)
- Status
- COMPLETED
- Phase
- PHASE2